Illumina (ILMN) – Import Ban Lifted

Last week, it was reported that the Chinese Ministry of Commerce (MOFCLM) announced it will lift the existing import ban on Illumina (ILMN) sequencers, effective November 10th. This decision followed framework agreements reached during recent U.S.-China trade talks in Malaysia. Although Illumina remains on the “unreliable entity” list, Chinese firms will now be permitted to apply for government approval to resume transactions with the company.

Canaccord Genuity analyst Kyle Mikson would say that this decision marks a significant reversal from China’s original March 2025 ban of Illumina’s sequencers, which materially impacted the company. Illumina has guided to $220M in revenue from the broader China region, down from $308M in 2024 and reported a 54% Y/Y decline in its instruments business in the region in Q3. “We view the lifting of the ban as a highly promising development that could enable Illumina to recapture a meaningful portion of lost revenue. While the pace of recovery will depend on how the application and approval process unfold (with Chinese firms required to demonstrate compliance with government requirements) we view this as a critical first step toward normalizing cross-broader operations and revenue contribution from China.”

Similarly, Stifel analyst Daniel Arias would highlight that ILMN did not change their guidance based on this news. It remains to be seen to what extent customers in China are eager to pursue government approval in order to purchase a sequencer amidst the vicissitudes of trade policy and geopolitical tensions that are in place. “But some surely will, and even a modest uptick in new instrument purchases and stocking/restocking of consumables could have an impact on total FY26 revenues.”